Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 24 Sept 2026 for Theravance Biopharma, Inc.. Read the official filing
Filing timeline
BuySaleRick E. Winningham
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Rick E. Winningham: trading record in brief
This profile gathers the share dealings of Rick E. Winningham across 2 companies, led by Theravance Biopharma, Inc. and Jazz Pharmaceuticals plc. In total, 46 filings cover trades dated from 20 May 2021 to 23 September 2026.
No open-market purchase appears, only 2 sales worth €1.0M. Other entries cover 35 share grants.
On 24 September 2026 came the latest disclosure, a transaction in Theravance Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rick E. Winningham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
1,382,272 sharesOrdinary SharesSEC:0001302443-26-000018:0
151,875 sharesOrdinary SharesSEC:0001302443-26-000018:1
76,875 sharesOrdinary SharesSEC:0001302443-26-000018:2
23,400 sharesOrdinary SharesSEC:0001302443-26-000018:3
92,567 sharesOrdinary SharesSEC:0001302443-26-000018:4
20,034 shares@ US$16.950.038% mcap6.1% of flowOrdinary SharesSEC:0001302443-26-000012:0
1,605 shares0Ordinary SharesSEC:0001302443-26-000010:0
75,000 shares0Ordinary SharesSEC:0001302443-26-000004:0
74,975 shares@ US$19.6627.8% of flowOrdinary SharesSEC:0001302443-26-000002:0
9,900 shares0Ordinary SharesSEC:0001302443-25-000008:0
5,500 shares@ US$180.859784.0% of flowOrdinary SharesSEC:0001302443-25-000006:0
15,394 shares@ US$13.395.4% of flowOrdinary SharesSEC:0001415889-25-022803:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000078:0
20,000 shares0Ordinary SharesSEC:0001415889-25-018221:0
9,600 shares0Ordinary SharesSEC:0001415889-25-017585:0
15,364 shares@ US$9.453.7% of flowOrdinary SharesSEC:0001415889-25-014263:0
2,178 shares@ US$9.350.6% of flowOrdinary SharesSEC:0001415889-25-006684:0
35,129 shares@ US$9.669.4% of flowOrdinary SharesSEC:0001415889-25-005357:0
15,997 shares@ US$9.974.3% of flowOrdinary SharesSEC:0001415889-24-027573:0
3,193 shares@ US$9.570.8% of flowOrdinary SharesSEC:0001415889-24-027297:0
15,997 shares@ US$8.223.4% of flowOrdinary SharesSEC:0001415889-24-022092:0
3,252 shares@ US$7.830.7% of flowOrdinary SharesSEC:0001415889-24-021057:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000079:0
15,997 shares@ US$9.103.9% of flowOrdinary SharesSEC:0001415889-24-014141:0
2,068 shares@ US$9.850.5% of flowOrdinary SharesSEC:0001415889-24-013612:0
25 of 46 declarations
